Monte Rosa Therapeutics, Inc. (GLUE)

Monte Rosa Therapeutics Revenue

Monte Rosa Therapeutics had revenue of $23.19M in the quarter ending June 30, 2025, with 394.01% growth. This brings the company's revenue in the last twelve months to $177.99M, up 2,990.57% year-over-year. In the year 2024, Monte Rosa Therapeutics had annual revenue of $75.62M.

• Revenue (ttm): $177.99M
• Revenue Growth: +2,990.57%
• P/S Ratio: 2.22
• Revenue / Employee: $1,328,254
• Employees: 134
• Market Cap: 297.68M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	75.62M	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.